4D Molecular Therapeutics, Inc. (FDMT)
10.73
-0.10
(-0.92%)
USD |
NASDAQ |
Dec 11, 12:22
4D Molecular Therapeutics Market Cap: 613.06M for Dec. 11, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Aura Biosciences, Inc. | 412.14M |
| NovaBay Pharmaceuticals, Inc. | 361.65M |
| Palatin Technologies, Inc. | 25.10M |
| Theriva Biologics, Inc. | 7.760M |
| Oragenics, Inc. | 0.7892M |
Market Cap Related Metrics
| PS Ratio | 4774.66 |
| PEG Ratio | -0.0392 |
| Price to Book Value | 1.662 |
| Price | 10.73 |
| Earnings Yield | -36.68% |
| PEGY Ratio | -0.0392 |